Post-pandemic surge in prescriptions for ADHD meds costs €30 million
The number of people receiving medication for ADHD under free or subsidised drug schemes has surged by 150% since the beginning of the Covid-19 pandemic, costing more than €30 million in the past five years
A total of 25,715 patients were prescribed medication for the neurodevelopmental disorder on the medical card or other public health schemes last year, compared to 10,327 in 2020.
Advertisement
The annual cost of the medication, which is most often a stimulant called methylphenidate, also more than doubled during that period, rising from €4.1 million in 2020 to €9.3 million last year.
Last year, 11,357 patients were prescribed drugs for ADHD on the medical card, while 12,105 patients who were medicated for the disorder received reimbursements under the Drugs Payment Scheme (DPS).
A further 2,253 people received medication for ADHD under the Long-Term Illness (LTI) scheme.
Galway was the Local Health Office (LHO) area with the highest number of patients who were prescribed ADHD drugs under the medical card scheme last year, with 833. This was followed by Laois-Offaly, where 557 medical-card holders received the medication.
Advertisement
The LHO area with the highest number of patients who received reimbursements for ADHD medication under the DPS in 2024 was Dublin South East, with 1,261, followed by Dun Laoghaire with 818.
Earlier this year, researchers at the University of Huddersfield and Aston University attributed a reported rise in ADHD diagnoses since the pandemic to increased awareness of the disorder via social media.
They also said there was a 'strong association' between the impact of the pandemic and the worsening of ADHD symptoms, which include inattention, hyperactivity, and emotional dysregulation.
Drugs used to treat the disorder include methylphenidate, which is better known by the brand names Ritalin, Concerta and Delmosart, as well as two other stimulants: dexamfetamine and lisdexamfetamine.
Advertisement
In April, Government Chief Whip Mary Butler, the minister of state with responsibility for mental health, suggested that a surge in young children with ADHD was driving waiting lists for CAMHS.
Ireland
Irish people left 'high and dry' in cost of living...
Read More
Records released under freedom of information laws show that the number of patients prescribed medication for ADHD on the medical card scheme has increased by 69 per cent since 2020.
The number of people prescribed ADHD on the DPS increased by 655 per cent from 1,604 to 12,105 during the same period, while the number of patients receiving ADHD drugs on the LTI scheme increased by 12 per cent.
The LHO area with the lowest number of patients prescribed medication for ADHD under the medical card scheme last year was West Cork, with 79. It was also the lowest LHO area under the LTI scheme, with seven.
A total of 80 patients on the DPS were prescribed ADHD drugs in Roscommon in 2024, according to the records released by the Health Service Executive (HSE).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
32 minutes ago
- The Guardian
RFK Jr's federal vaccine panel votes against chemical in flu vaccines
A critical federal vaccine panel has recommended against seasonal influenza vaccines containing a specific preservative – a change likely to send shock through the global medical and scientific community and possibly impact future vaccine availability. The panel was unilaterally re-made by health secretary Robert F Kennedy Jr, a vaccine skeptic who has urged against the use of thimerosal despite a lack of evidence of real-world harm. Across three votes, members voted in favor of restricting thimerosal in seasonal influenza vaccines across all age groups – with five in favor of the restriction, one abstention and one vote against. 'The risk from influenza is so much greater than the nonexistent – as far as we know – risk from thimerosal,' said Dr Cody Meissner, a panel member and professor of pediatrics at Dartmouth's Geisel School of Medicine who was the lone 'no' vote. 'I would hate for a person not to receive the influenza vaccine because the only availability preparation contains thimerosal – I find that very hard to justify.' The panel, formally called the Advisory Committee for Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC), is a critical link in the vaccine distribution pipeline – informing health insurers and clinicians alike about which vaccines to give patients. Kennedy fired all 17 former members of the panel in June, citing conflicts of interest, and appointed eight new members, all of whom are ideological allies of the secretary. None of the new members have published written conflict of interest disclosures or been added to a Trump administration-developed conflict of interest tracker for ACIP members, as of Thursday morning. 'There is a very big difference between what was shared at the meeting versus what is reality,' said Dr Sean O'Leary, chair of the American Academy of Pediatrics Committee on Infectious Diseases. 'The science on thimerosal is settled, and the rhetoric being used to suggest otherwise is misleading and harmful.' Rather than vote on an agenda that had once included seasonal recommendations for Covid-19 and the vaccine against human papilloma virus (HPV), ACIP added the controversial focus of thimerosal in vaccines. The panel affirmed that the influenza vaccine is recommended for Americans older than six months. Although multiple studies have found no real-world harm, the preservative has been a talking point of anti-vaccine advocates for decades. Multiple representatives of physicians associations urged the panel to reject the recommendation against thimerosal in the meeting. Thimerosal is used in about 5% of multidose seasonal influenza vials, and is known to be more cost effective than single-dose formulations. It is unclear how the vote will impact flu vaccine availability before the upcoming flu season, particularly for clinics that rely on such formulations. Thimerosal has been used as a preservative in vaccines since before the second world war. In the early 2000s, thimerosal was removed from all routine pediatric and most adult vaccines as a precautionary measure – a decision that was criticized by experts who argued it sent mixed messages about a preservative that had not been found to cause harm. The issue has since been considered settled by mainstream medicine. Thimerosal is an ethylmercury-based preservative. Ethylmercury is different from the kind of mercury found in seafood, called methylmercury. Ethylmercury has a much shorter half-life in the blood and brain, about seven days and 30 days respectively, compared to methylmercury, which has an approximately 44-58 day half-life and accumulates in the brain. The amount of ethylmercury contained in a flu vaccine (25 micrograms) is about half of that contained in a 3-ounce serving of canned tuna fish (40 micrograms). Repeated, large studies conducted across several countries have found no association between thimerosal and neurological effects. A presentation from CDC career scientists that was initially expected to go through some of this substantial data was removed before the panel reconvened on Thursday. In response to a question about the slapped down presentation, ACIP member Dr Robert Malone, a well-known anti-vaccine activist, said: 'That article was not authorized by the office of the secretary and was removed.' The panel instead heard a presentation from Lyn Redwood, a nurse practitioner who founded the World Mercury Project, the predecessor to Kennedy's anti-vaccine advocacy group Children's Health Defense. Prior to the meeting, her presentation was found to include a reference to a study that appeared to be made up. 'This is an old issue that has been addressed in the past and there are many issues we could discuss,' said Meissner. Responding to criticism of Redwood's presentation, ACIP chair Dr Martin Kulldorff, a former Harvard professor who was fired for refusing the Covid-19 vaccine, said: 'It's inappropriate to dismiss a presentation just because the person does not have a PhD or MD.' The decision from ACIP could have global implications, because vaccines used around the world rely on thimerosal as a preservative in multidose vials, which are less expensive. 'I know ACIP is focused on the US, but recommendations that the ACIP makes are followed among many countries around the world,' said Meissner. 'Removing thimerosal from all vaccines used in other countries, for example, is going to reduce access to these vaccines, it will increase costs, and I think it's important to note that no study has ever indicated any harm from thimerosal.'
Daily Mail
an hour ago
- Daily Mail
Pregnant Republican forced to evacuate Florida office after imminent death threats following her painful revelation
Florida Republican Kat Cammack shared Wednesday that her district office had to be evacuated due to death threats she received following a Wall Street Journal story published earlier this week detailed her experiences with an ectopic pregnancy last year. Cammack, 37, is currently pregnant and expecting her first child in mid-August. In a post on X, formerly Twitter, the congresswoman spoke of 'imminent death threats against me, my unborn child, my family and my staff' based on her revealing her story about a 'nonviable pregnancy with no heartbeat.' 'Since then, we've received thousands of hate-filled messages and dozens of credible threats from pro-abortion activists, which law enforcement is actively investigating,' she added, noting the uptick of violent threats against elected officials. In a statement sent to the Daily Mail by Cammack's office she also noted: 'This is the unacceptable reality we're facing: sharing a personal health story in an effort to improve healthcare for women and their children can lead to threats, harassment, and evacuation orders'. 'This should be a wake-up call. Women deserve better. And so does the national healthcare dialogue, Cammack added. The threats come just over a week after a Minnesota lawmaker and her husband were assassinated at their home by a gunman. Cammack also clarified that she did not vote for Florida's heartbeat law since she serves as a U.S. congresswoman, not a state legislature. Florida's heartbeat law, passed in 2023, bans abortion once a fetal heartbeat can be detected — typically around six weeks of pregnancy. 'Let me be clear: I will not be intimidated. I won't back down in the fight for women and families. Ensuring women have the resources and care they deserve is critical. We need real conversations about maternal healthcare in America—conversations based on truth, not fear,' Cammack said. Today, we had to evacuate our offices due to imminent death threats against me, my unborn child, my family, and my staff. These threats erupted after the Wall Street Journal reported on my life-threatening ectopic pregnancy—a nonviable pregnancy with no heartbeat. Since then,… — Rep. Cammack Press Office (@RepKatCammack) June 26, 2025 The Wall Street Journal reported that Cammack was about five weeks pregnant when she required a methotrexate injection to treat an ectopic pregnancy — a condition in which the embryo cannot survive. Cammack is a co-chair of the House Pro-Life Caucus, and opposes abortion, but backs exemptions in the case of rape, incest and when the life of the mother is in danger. Cammack's team said some of the threats came in as comments on a series of photos she and her husband Matt Harrison took to celebrate her pregnancy.
BreakingNews.ie
2 hours ago
- BreakingNews.ie
Investment leads to drastically different productivity changes across hospitals
University Hospital Limerick (UHL) has seen the highest productivity increase since before Covid-19, according to a new analysis of HSE data. The Department of Health has launched a new dashboard which examines productivity improvements compared to increases in expenditure and staffing. Advertisement Officials have designed a 'composite activity output' which is a high-level illustration of aggregated, cumulative activity in each hospital setting and is based on the costs of delivering inpatient, day case, outpatient and emergency department care. It can be used to distil years-long increases in productivity across different types of care into a single figure to allow for comparisons against workforce and expenditure increases. Officials said it showed that some hospitals are 'notably better' at converting their input into activity, adding that they wish to determine the reasons for that. The data shows that UHL was the hospital with the most productivity change between 2019 and 2024, at up 36 per cent – although the boost followed some of the highest levels of increased investment. Advertisement On roughly the same percentage workforce and expenditure increases as UHL, University Hospital Waterford was only able to translate that investment into a 17 per cent increase of productivity, less than half that of the top-performing hospital. Still, UH Waterford was the fourth-highest performing hospital on metric of productivity increases, behind UHL, Connolly Hospital Blanchardstown, and Tallaght University Hospital. The worst performing hospitals were St Vincent's University Hospital and St James' Hospital with roughly 3 per cent productivity increases, followed by MRH Portlaoise – on just 0.19 per cent. This was with a 42 per cent increase in expenditure and 21 per cent increase in workforce. Advertisement While MRH Portlaoise was towards the lower end of the scale when it came to increases on expenditure and whole-time equivalents, it still under performed against other hospitals with similar support. On even lower percentage increases on those metrics, Our Lady of Lourdes Hospital vastly outperformed Portlaoise with a 13.51 per cent increase in productivity. Elsewhere, the data also examines the number of appointments taken by consultants at hospitals across the country and compares that to a 2016 baseline. Nationally, the appointment-per-consultant stood at 1,686 in 2016 but has declined to 1,216 in 2024 – despite the number of whole-time equivalent consultants increasing by 70 per cent in that period. Advertisement The Department of Health says it means that consultants across the country could have 40% more appointments last year if they had been operating at the same productivity in 2016. The two worst performing hospitals under this metric are CHI at Tallaght and Croom Orthopedic Hospital. CHI at Tallaght had 16,390 appointments last year but the Department estimates it could have 2.7 times as many based on 2016 levels of productivity. The data also estimates that Croom could have more than tripled its 8,950 appointments last year by the same calculation. Advertisement MRH Portlaoise, CHI at Tallaght and Croom Orthopedic Hospital have been contacted for comment.
